Skip to main content
Fuan Pharmaceutical （Group）co.,Ltd logo

Fuan Pharmaceutical （Group）co.,Ltd — Investor Relations & Filings

Ticker · 300194 ISIN · CNE1000011G4 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,013 across all filing types
Latest filing 2022-04-25 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 300194

About Fuan Pharmaceutical （Group）co.,Ltd

https://www.fapharm.com

Fuan Pharmaceutical (Group) Co., Ltd. is an integrated pharmaceutical enterprise specializing in the research, development, production, and distribution of a wide range of chemical drugs. The company operates across the entire value chain, encompassing pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and finished dosage forms. Its product portfolio primarily focuses on anti-infectives, particularly cephalosporins and penicillins, as well as treatments for cardiovascular diseases, oncology, and respiratory conditions. Fuan Pharmaceutical maintains large-scale manufacturing facilities and emphasizes technological innovation to support its diverse pipeline of generic and specialized medications. The group serves both domestic and international markets, providing essential healthcare solutions through its network of subsidiaries and specialized production bases.

Recent filings

Filing Released Lang Actions
2021年年度审计报告
Audit Report / Information Classification · 95% confidence The document contains a detailed audit report including the auditor's opinion, basis for the opinion, key audit matters, and extensive financial statements such as consolidated and parent company balance sheets, profit and loss statements, cash flow statements, and notes for the fiscal year ending December 31, 2021. The presence of an auditor's report with audit opinion and detailed financial statements indicates this is a standalone audit report rather than a full annual report or other filing. The document length is substantial (15,000 characters) and contains actual financial data, not just an announcement or certification. Therefore, the document fits the definition of an Audit Report / Information (AR). FY 2021
2022-04-25 Chinese
章程修正案（2022年4月）
Governance Information Classification · 95% confidence The document is titled '章程修正案' which translates to 'Articles of Association Amendment'. It details amendments to the company's articles of association, including changes to the company's business scope. The document references approval by the board of directors and pending approval by the shareholders' meeting and market supervision authority. This type of document relates to governance and internal company rules rather than financial results, audit, or other report types. It is not a report publication announcement or a certification. Therefore, the most appropriate classification is Governance Information (CGR). The document length is short but contains substantive governance content, not just an announcement.
2022-04-25 Chinese
2021年年度财务报告
Annual Report Classification · 95% confidence The document contains detailed consolidated and parent company financial statements including balance sheets, income statements (profit and loss), and cash flow statements for the fiscal year ending December 31, 2021. It includes comprehensive financial data such as assets, liabilities, equity, revenues, expenses, profits, and notes references. The length is substantial (15,000 characters) and the content is the actual financial report, not an announcement or summary. The presence of full financial statements and notes indicates this is a full annual report. Therefore, the document is classified as an Annual Report (10-K equivalent). FY 2021
2022-04-25 Chinese
关于Red Realty LLC 的计提资产减值公告
Regulatory Filings Classification · 95% confidence The document is an announcement by 福安药业（集团）股份有限公司 regarding the impairment provision for an asset (Red Realty LLC). It details the background of the investment, reasons for impairment, the amount of impairment, and the impact on the company's financials. The document includes board and supervisory committee approvals and independent director opinions. It is a regulatory announcement about an accounting event (asset impairment) rather than a full financial report or audit report. The document length is under 5,000 characters and is structured as a formal announcement of a specific financial event, not a comprehensive report or audit. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2022-04-25 Chinese
福安药业：2021年度内部控制评价报告
Audit Report / Information Classification · 95% confidence The document is titled as an "Internal Control Evaluation Report" for the year 2021 by 福安药业（集团）股份有限公司. It discusses the evaluation of the company's internal control effectiveness as of December 31, 2021, covering financial and non-financial internal control deficiencies, governance structure, risk management, and control measures. The document is detailed and contains substantive content about internal control evaluation, including standards, scope, and conclusions. It is not an announcement of a report publication but the report itself. This type of document fits best under the category of Audit Report / Information (AR), as it is a standalone internal control evaluation report related to audit and control processes, not a full annual report or other categories like management changes or earnings release. FY 2021
2022-04-25 Chinese
关于召开2021年年度股东大会的通知
AGM Information Classification · 95% confidence The document is a detailed notice about the convening of the 2021 Annual General Meeting (AGM) of 福安药业 (Fuan Pharmaceutical Group Co., Ltd.). It includes information about the meeting date, voting procedures, agenda items (such as approval of the 2021 annual report, audit report, profit distribution plan, and board reports), registration details, and proxy forms. The document does not contain the actual annual report or financial statements but rather serves as an official announcement and invitation to shareholders to attend and vote at the AGM. The document length is 4326 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, it fits the category of AGM Information (AGM-R).
2022-04-25 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.